Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed with results

Key Signals

6 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (12)
P 2 (3)

Trial Status

Completed8
Recruiting3
Unknown2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
Showing all 15 trials

Research Network

Activity Timeline